<DOC>
	<DOCNO>NCT01503580</DOCNO>
	<brief_summary>Overactive bladder syndrome ( OAB ) affect around 17 % female population . However , etiology OAB complicate unclear many aspect . In particular , research psychiatric aspect etiology OAB paucity . Besides , research prognostic factor impact cardiovascular system OAB treatment also paucity . Therefore aim investigator study ( 1 ) analyze etiology OAB psychiatric aspect ; ( 2 ) analyze prognostic factor associate tolterodine treatment ; ( 3 ) analyze difference cardiac conduction heart rate variability tolterodine treatment ; ( 4 ) analyze difference arterial stiffness non-OAB OAB female patient , tolterodine treatment .</brief_summary>
	<brief_title>Studies Psychiatric Predisposing Factors , Treatment-related Cardiovascular Effects , Prognostic Factors Associated With Antimuscarinic Drug ( Tolterodine ) Female Overactive Bladder Syndrome</brief_title>
	<detailed_description />
	<mesh_term>Urinary Bladder , Overactive</mesh_term>
	<mesh_term>Solifenacin Succinate</mesh_term>
	<mesh_term>Tolterodine Tartrate</mesh_term>
	<mesh_term>Muscarinic Antagonists</mesh_term>
	<criteria>case female patient low urinary tract symptom</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>October 2013</verification_date>
</DOC>